Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial

BACKGROUND: Mebendazole is an anthelmintic drug introduced for human use in 1971 that extends survival in preclinical models of glioblastoma and other brain cancers. METHODS: A single-center dose-escalation and safety study of mebendazole in 24 patients with newly diagnosed high-grade gliomas in com...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallia, Gary L, Holdhoff, Matthias, Brem, Henry, Joshi, Avadhut D, Hann, Christine L, Bai, Ren-Yuan, Staedtke, Verena, Blakeley, Jaishri O, Sengupta, Soma, Jarrell, T Che, Wollett, Jessica, Szajna, Kelly, Helie, Nicole, Mattox, Austin K, Ye, Xiaobu, Rudek, Michelle A, Riggins, Gregory J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817892/
https://www.ncbi.nlm.nih.gov/pubmed/33506200
http://dx.doi.org/10.1093/noajnl/vdaa154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817892/
https://www.ncbi.nlm.nih.gov/pubmed/33506200
http://dx.doi.org/10.1093/noajnl/vdaa154

Ejemplares similares